Cardiothoracic Department, Division of Cardiology and Postgraduate School in Cardiovascular Sciences, University of Trieste, Trieste, Italy.
Pulmonary Hypertension National Service, Hammersmith Hospital Imperial College NHS Trust, London, UK.
J Cardiovasc Med (Hagerstown). 2019 Apr;20(4):159-168. doi: 10.2459/JCM.0000000000000774.
: Chronic thromboembolic disease (CTED), especially when associated with pulmonary hypertension (CTEPH), is a fearsome and under-diagnosed but potentially curable complication of pulmonary embolism, thanks to recent therapeutic options. Aspecific symptoms and signs make its diagnosis challenging, requiring clinicians to be ready to suspect its presence in patients with dyspnea of unknown origin or persistent symptoms after acute pulmonary embolism. The aim of this review is to provide an update to the general practitioner or the specialist physician on the state of the art regarding the epidemiology, pathophysiology and clinical management of chronic thromboembolic syndromes.
慢性血栓栓塞性疾病(CTED),特别是与肺动脉高压(CTEPH)相关时,是一种可怕且诊断不足但具有潜在可治愈性的肺栓塞并发症,这要归功于最近的治疗选择。其无特异性的症状和体征使其诊断具有挑战性,需要临床医生准备好在有不明原因呼吸困难或急性肺栓塞后持续存在症状的患者中怀疑其存在。本综述的目的是为全科医生或专科医生提供有关慢性血栓栓塞综合征的流行病学、病理生理学和临床管理方面的最新知识。